Skip to main content

Table 1 Overall Baseline Characteristics and Comparison between rebleeding and no-rebleeding group

From: Development and validation of a model to predict rebleeding within three days after endoscopic hemostasis for high-risk peptic ulcer bleeding

Characteristic

Total

Rebleeding

Non-rebleeding

P

N = 386

N = 48

N = 338

Age, median (IQR)

56 (43–65)

54 (31.5–65)

56 (43–65)

0.229

Sex: male [No. (%)]

313 (81.1)

37 (77.1)

276 (81.7)

0.555

Alcohol use [No. (%)]

64 (16.6)

5 (10.4)

59 (17.5)

0.299

Smokers [No. (%)]

119 (30.8)

9 (18.8)

110 (32.5)

0.077

Haematemesis [No. (%)]

194 (50.3)

40 (83.3)

154 (45.6)

0.001

Medication history

 Use of NSAIDs [No. (%)]

22 (5.7)

2 (4.2)

20 (5.9)

0.875

 Use of anticoagulants [No. (%)]

4 (1)

0

4 (1.2)

1

PU bleeding history [No. (%)]

73 (18.9)

5 (10.4)

68 (20.1)

0.108

Coexisting diseases [No. (%)]

 Hypertension

90 (23.3)

10 (20.8)

80 (23.7)

0.664

 Diabetes mellitus

34 (8.8)

3 (6.3)

31 (9.2)

0.692

Shock [No. (%)]

53 (13.7)

23 (47.9)

30 (8.9)

< 0.001

Systolic blood pressure [mmHg, median (IQR)]

114 (103–128)

110 (96–131.5)

114 (104–127)

0.484

Diastolic blood pressure (mmHg, mean ± SD)

70.14 ± 0.68

68.88 ± 2.37

70.32 ± 0.70

0.560

Heart rate [beats/min, median (IQR)]

86 (73–99)

99 (80.5–109.5)

85 (73–97)

< 0.001

Surgery due to rebleeding [No. (%)]

15 (3.9)

15 (31.1)

0

< 0.001

Mortality [No. (%)]

16 (4.1)

16 (33.3)

0

< 0.001

Blood transfusion [No. (%)]

192 (49.7)

33 (68.8)

159 (47)

0.005

Hospitalization stay, median (IQR)

7 (5–10)

12 (7–20)

6 (5–9)

< 0.001

Glasgow-Blatchford score, median (IQR)

10 (8–12)

10 (8–13)

10 (8–12)

0.138

Rockall score, median (IQR)

4 (3–4)

4 (3–5)

4 (3–4)

0.074

AIMS65 score, median (IQR)

1 (0–1)

2 (1–3)

0 (− 1)

< 0.001